Article Listing - Nycomed wins patent case against Applied

MMD'S 5HT3 RECEPTOR ANTAGONIST

9 March 1992

The pharmacokinetic properties of a new anti-emetic 5-HT3 receptor antagonist from Marion Merrell Dow, MDL 73,147EF, will be described at...

FIRST QUARTER LOSS AT ALLELIX

17 February 1992

Canadian biopharmaceutical concern Allelix has reported a loss of around C$300,000 ($254,790) for the first quarter ended November 30, 1991....

RHONE-POULENC UNITS IN AIDS JV

17 February 1992

Rhone-Poulenc Rorer, the Franco-American health care concern and the Pasteur Merieux Connaught Group, a vaccines manufacturer which is owned by...

RISING HEALTH CARE COSTS IN SPAIN

17 February 1992

Family expenditure in Spain on medication has progressively fallen in recent years, and at the same time, the costs of...

AIDS TREATMENT FROM JOHNSON MATTHEY

17 February 1992

A new potential treatment for AIDS patients has been developed by the precious metals group of UK-based Johnson Matthey. As...

CHINESE DRUG PRODUCTION IN 1991

17 February 1992

Chinese pharmaceutical production was valued at 39.9 billion yuan ($7.4 billion) in 1991, reports the People's Daily, quoted in...

USTR INVITES COMMENTS ON INDIAN PATENT ACTION

17 February 1992

The US Trade Representative, Carla Hills, has intensified her country's pressure on India over the issue of intellectual property rights...

MORTALITY BENEFIT WITH GYNEX' OXANDRIN

17 February 1992

Gynex Pharmaceuticals Inc has reached an agreement with the US Department of Veterans Affairs, giving it access to and use...

MYLAN CLAIMS FDA DISCRIMINATION

17 February 1992

The US Food and Drug Administra-tion is allegedly withholding appr-oval of drugs for Mylan Laborat-ories because the company revealed malpractices...

US PRICE DISCOUNTING

17 February 1992

Glaxo Inc has announced it will offer price discounts to US public health clinics serving the poor, in order to...

Showing 94741-94750 of 95329 articles

Go to beginningPreviousNextGo to end